Jefferies Financial Group Inc.
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 96223
NEW YORK, NY
Position in IMDX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$106,790
New position
Shares Held
18,100
first reported quarter
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 40 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $239,574,818 across 21 Diagnostics & Research names. IMDX ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
193,340 | $96,932,942 | |
| 2 | GRAL |
GRAIL, Inc.
|
724,000 | $49,427,480 | |
| 3 | QGEN |
Qiagen N.V.
|
618,798 | $24,195,001 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
84,902 | $16,404,764 | |
| 5 | CSTL |
Castle Biosciences Inc
|
647,391 | $15,440,275 | |
| 6 | A |
Agilent Technologies, Inc.
|
63,180 | $8,392,199 | |
| 7 | GH |
Guardant Health, Inc.
|
35,629 | $5,345,418 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
18,270 | $4,143,453 |
All Filings in IMDX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,790 | 18,100 | Shares | Defined | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||